ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
6,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
8,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
9,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
9,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
9,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
10,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
11,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
12,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
13,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
14,1,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
15,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
16,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,2,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
16,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
16,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
17,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
18,1,Amaurosis fugax,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
19,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
20,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
20,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
20,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
21,1,Acne,Acnes,Skin appendage conditions,Skin,N
21,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
22,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
22,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
23,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
23,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
23,3,Type III immune complex mediated reaction,Allergic conditions NEC,Allergic conditions,Immun,N
24,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
25,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
25,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
25,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
26,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
26,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
26,3,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
27,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
27,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
27,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
27,5,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
27,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
27,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
28,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
28,2,Headache,Headaches NEC,Headaches,Nerv,N
28,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
28,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
30,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
30,2,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
31,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
32,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
32,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
34,1,Headache,Headaches NEC,Headaches,Nerv,N
34,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
34,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
35,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
36,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
36,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
37,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
38,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
38,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
38,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
39,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
40,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
40,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
40,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
41,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
42,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
43,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
44,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
45,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
46,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
47,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
48,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
48,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
48,3,Migraine,Migraine headaches,Headaches,Nerv,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
49,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
49,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
49,5,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
49,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
50,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
50,3,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
51,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
51,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
51,3,Vocal cord paresis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
51,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
52,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
53,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
53,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
54,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
55,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
55,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
55,3,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
55,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
56,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
56,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
56,3,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
56,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
56,5,Staphylococcal skin infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
57,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
58,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
59,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
59,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
59,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
60,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
61,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
62,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
62,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
62,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
63,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
63,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
64,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
64,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
65,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
66,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
66,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
66,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
67,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
67,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
68,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
69,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
69,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
71,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
71,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
73,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
73,2,Lhermitte's sign,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
73,3,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
74,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
75,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
75,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
75,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
75,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
75,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
77,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
78,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
78,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
78,3,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
79,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
80,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
80,2,Headache,Headaches NEC,Headaches,Nerv,N
80,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
80,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
80,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
81,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
81,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
81,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
81,6,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
81,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
81,8,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
81,9,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
81,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,12,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
81,13,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
81,14,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
81,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
82,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
82,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
82,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
82,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,6,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
82,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
82,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
83,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
83,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
83,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
83,4,Increased upper airway secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
83,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
83,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
83,7,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
83,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
83,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
83,10,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
83,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
83,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
84,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
84,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
84,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
84,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
85,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
86,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
87,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
87,3,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
88,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
88,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
88,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
88,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
88,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
89,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
89,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
89,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
90,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
91,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
92,1,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
93,1,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
93,2,Von Willebrand's disease,Coagulation disorders congenital,Blood and lymphatic system disorders congenital,Cong,N
94,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
94,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
94,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
94,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
95,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
95,2,Headache,Headaches NEC,Headaches,Nerv,N
95,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
96,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
98,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
98,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
99,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
99,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
99,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
101,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
102,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
103,1,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
104,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
104,2,Tumour perforation,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
105,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
106,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
107,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
108,1,Device related thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
109,1,Madarosis,Alopecias,Skin appendage conditions,Skin,N
110,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
110,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
110,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
110,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
111,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
112,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
113,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
114,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
114,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
114,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
114,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
114,5,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
115,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
116,1,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
116,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
116,3,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
117,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
117,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
118,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
118,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
118,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
120,1,Headache,Headaches NEC,Headaches,Nerv,N
121,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
122,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
122,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
122,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
123,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
123,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
124,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
125,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
126,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
126,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
126,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
128,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
129,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
129,2,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
129,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
130,2,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
131,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
132,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
132,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
133,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
134,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
134,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
134,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
136,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
136,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
136,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
136,4,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
137,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
137,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
138,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
139,1,Headache,Headaches NEC,Headaches,Nerv,N
140,1,Headache,Headaches NEC,Headaches,Nerv,N
141,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
141,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
141,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
141,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
142,1,Headache,Headaches NEC,Headaches,Nerv,N
143,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
144,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
144,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
144,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
144,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
144,5,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
145,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
145,2,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
146,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
146,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
146,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
146,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
146,5,Nail bed disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
146,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
146,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
147,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
148,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
149,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
150,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
150,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
150,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
151,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
152,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
153,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
154,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
155,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
156,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
157,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
158,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
158,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
158,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
159,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
159,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
159,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
159,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
160,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
161,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
161,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
161,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
162,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
163,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
164,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
165,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
165,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
166,1,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
167,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
167,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
168,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
168,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
169,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
169,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
169,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
170,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
170,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
171,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
172,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
172,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
173,1,Abdominal wall abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
173,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
173,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
174,2,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
174,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
174,4,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
174,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
174,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
174,7,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
174,8,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
174,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
174,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
174,11,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
175,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
175,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
175,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
175,4,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
175,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
175,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
176,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
177,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
178,2,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
179,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
180,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
181,1,Deafness,Hearing losses,Hearing disorders,Ear,N
181,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
181,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
181,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
181,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
182,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
183,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
183,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
183,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
183,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
183,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
183,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
183,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
183,8,Headache,Headaches NEC,Headaches,Nerv,N
183,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
183,10,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
183,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
183,12,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
183,13,Skin graft infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
183,14,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
183,15,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
184,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
184,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
184,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
184,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
184,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
184,6,Headache,Headaches NEC,Headaches,Nerv,N
184,7,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
184,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
184,9,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
184,10,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
184,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
184,12,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
184,13,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
184,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
184,15,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
184,16,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
185,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
185,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
185,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
185,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
185,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
185,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
185,7,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
185,8,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
185,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
186,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
186,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
187,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
187,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
189,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
190,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
190,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
191,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
191,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
192,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
192,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
192,3,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
192,4,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
193,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
194,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
195,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
196,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
196,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
197,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
198,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
198,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
198,3,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
198,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
199,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
199,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
200,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
200,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
200,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
201,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
201,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
202,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
203,1,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
204,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
204,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
205,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
206,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
206,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
206,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
206,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
206,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
208,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
208,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
209,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
211,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
212,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
212,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
212,3,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
212,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
212,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
215,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
216,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
216,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
216,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
216,4,Urethral haemorrhage,Urethral disorders NEC,Urethral disorders (excl calculi),Renal,N
217,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
218,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
218,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
219,1,Amylase decreased,Digestive enzymes,Gastrointestinal investigations,Inv,N
219,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
219,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
219,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
219,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
219,6,Head and neck cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
219,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
219,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
219,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
219,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
219,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
219,12,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
219,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
219,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
220,1,Amylase decreased,Digestive enzymes,Gastrointestinal investigations,Inv,N
220,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
220,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
220,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
220,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
220,6,Head and neck cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
220,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
220,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
220,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
220,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
220,11,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
220,12,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
220,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
221,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
222,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
222,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
222,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
223,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
224,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
224,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
225,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
225,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
226,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
226,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
226,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
227,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
227,2,High frequency ablation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
228,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
228,2,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
228,3,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
228,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
229,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
229,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
229,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
229,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
230,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
230,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
230,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
231,1,Catheter site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
231,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
232,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
232,2,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
232,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
233,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
233,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
233,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
233,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
234,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
235,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
235,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
235,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
235,4,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
235,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
235,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
235,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,1,Central vision loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
236,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
236,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
236,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
236,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
236,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
236,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
237,1,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
238,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
238,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
238,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
238,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
238,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
238,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
238,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
238,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
239,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
239,3,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
239,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
240,1,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
241,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
241,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
241,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
241,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
241,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
242,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
242,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
243,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
244,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
245,1,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
246,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
246,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
247,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
247,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
247,3,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
247,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
247,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
247,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
248,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
248,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
249,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
249,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
249,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
249,4,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
249,5,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
249,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
250,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
250,3,Cancer fatigue,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
250,4,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
250,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
250,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
250,7,Headache,Headaches NEC,Headaches,Nerv,N
250,8,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
251,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
251,2,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
252,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
252,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
252,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
252,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
252,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
253,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
254,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
255,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
256,1,Hepatic infarction,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
256,2,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
256,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
257,1,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
257,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
258,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
258,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
259,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
260,1,Carcinoembryonic antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
260,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
261,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
261,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
261,3,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
261,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
261,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
261,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
261,8,Headache,Headaches NEC,Headaches,Nerv,N
261,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
261,10,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
261,11,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
262,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
263,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
263,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
264,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
264,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
265,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
266,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
266,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
267,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
268,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
269,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
269,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
270,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
271,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
272,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
272,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
273,1,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
274,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
275,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
275,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
275,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
276,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
276,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
276,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
276,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
277,1,Headache,Headaches NEC,Headaches,Nerv,N
278,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
279,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
280,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
281,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
282,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
283,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
283,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
284,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
284,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
284,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
284,4,Sarcopenia,Muscle weakness conditions,Muscle disorders,Musc,N
284,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
285,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
286,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
286,2,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
286,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
287,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
288,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
289,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
290,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
291,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
291,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
291,3,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
291,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
291,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
291,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
292,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
292,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
293,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
293,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
294,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
294,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
294,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
295,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
295,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
295,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
296,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
297,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
297,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
297,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
298,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
298,2,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
298,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
298,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
298,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
298,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
299,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
299,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
299,3,Headache,Headaches NEC,Headaches,Nerv,N
299,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
300,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
300,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
300,4,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
300,5,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
301,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
301,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
301,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
301,4,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
301,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
301,6,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
301,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
301,8,Clostridial infection,Clostridia infections,Bacterial infectious disorders,Infec,N
301,9,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
301,10,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,11,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
301,12,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
301,13,Fournier's gangrene,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
301,14,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
301,15,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,16,Inflammation,Inflammations,General system disorders NEC,Genrl,N
301,17,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
301,18,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
301,19,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
301,20,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
301,21,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
301,22,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
301,23,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
301,24,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
301,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
301,26,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
301,27,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
301,28,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
301,29,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
301,30,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
301,31,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
301,32,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
302,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
303,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
308,1,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
308,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
308,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
309,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
309,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
309,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
310,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
310,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
310,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
310,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
311,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
311,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
312,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
313,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
314,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
314,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
314,4,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
314,5,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
314,6,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
314,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
314,8,Hepatic venous pressure gradient abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
314,9,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
314,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
314,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
314,12,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
314,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
314,14,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
314,15,Portal venous gas,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
314,16,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
314,17,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
315,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
316,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
318,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
319,1,Ocular retrobulbar haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
320,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
321,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
323,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
323,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
323,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
324,1,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
325,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
325,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
325,3,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
325,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
325,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,6,Peripancreatic fluid collection,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
325,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
325,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
325,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
325,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
326,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
327,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
328,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
328,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
328,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
328,4,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
328,5,Hepatic venous pressure gradient abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
328,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
328,7,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
328,8,Portal venous gas,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
328,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
329,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
330,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
330,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
330,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
331,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
331,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
331,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
333,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
333,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
333,3,Headache,Headaches NEC,Headaches,Nerv,N
333,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
334,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
334,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
335,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
335,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
335,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
336,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
337,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
338,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
339,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
340,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
340,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
340,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
340,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
341,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
342,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
343,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
343,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
343,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
343,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
344,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
344,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
344,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
344,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
344,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
344,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,1,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
345,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
346,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
346,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
346,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
346,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
346,6,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
